Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcos de Lima

Showing results (101-110 of 321) with videos related to

Pageof 33
Sort By:
Bone Marrow Transplantation|January 14, 2018
Management of important adverse events associated with inotuzumab ozogamicin: expert panel reviewPartow Kebriaei, Corey Cutler, Marcos de Lima, et al.
Blood|April 8, 2006
Allogeneic stem cell transplantation for patients with chronic myeloid leukemia and acute lymphocytic leukemia after Bcr-Abl kinase mutation-related imatinib failureElias Jabbour, Jorge Cortes, Hagop M Kantarjian, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 11, 2012
Dose intensification of busulfan in the preparative regimen is associated with improved survival: a phase I/II controlled, randomized studySimrit Parmar, Gabriela Rondon, Marcos de Lima, et al.
The Internet Journal of Hematology|October 31, 2014
The Impact of Pre-Stem Cell Transplant Ferritin Level on Late Transplant Complications: An Analysis to Determine the Potential Role of Iron Overload on Late Transplant OutcomesYvonne A Efebera, Rupinderjit S Thandi, Rima M Saliba, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 11, 2013
Proceedings from the National Cancer Institute's Second International Workshop on the Biology, Prevention, and Treatment of Relapse After Hematopoietic Stem Cell Transplantation: part III. Prevention and treatment of relapse after allogeneic transplantationMarcos de Lima, David L Porter, Minoo Battiwalla, et al.
Cancer|February 24, 2009
Low-dose azacitidine after allogeneic stem cell transplantation for acute leukemiaElias Jabbour, Sergio Giralt, Hagop Kantarjian, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 15, 2013
Feasibility of allografting in patients with advanced acute lymphoblastic leukemia after salvage therapy with inotuzumab ozogamicinPartow Kebriaei, Kaci Wilhelm, Farhad Ravandi, et al.
Leukemia Research|March 15, 2008
Altered gene expression in busulfan-resistant human myeloid leukemiaBenigno C Valdez, David Murray, Latha Ramdas, et al.
The New England Journal of Medicine|November 27, 2004
Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemiaVanderson Rocha, Myriam Labopin, Guillermo Sanz, et al.
Blood|September 24, 2008
BCR-ABL fusion transcript types and levels and their interaction with secondary genetic changes in determining the phenotype of Philadelphia chromosome-positive leukemiasDan Jones, Rajyalakshmi Luthra, Jorge Cortes, et al.
Pageof 33

Showing results (101-110 of 321) with videos related to

Sort By:
Pageof 33
Bone Marrow Transplantation|January 14, 2018
Management of important adverse events associated with inotuzumab ozogamicin: expert panel reviewPartow Kebriaei, Corey Cutler, Marcos de Lima, et al.
Blood|April 8, 2006
Allogeneic stem cell transplantation for patients with chronic myeloid leukemia and acute lymphocytic leukemia after Bcr-Abl kinase mutation-related imatinib failureElias Jabbour, Jorge Cortes, Hagop M Kantarjian, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 11, 2012
Dose intensification of busulfan in the preparative regimen is associated with improved survival: a phase I/II controlled, randomized studySimrit Parmar, Gabriela Rondon, Marcos de Lima, et al.
The Internet Journal of Hematology|October 31, 2014
The Impact of Pre-Stem Cell Transplant Ferritin Level on Late Transplant Complications: An Analysis to Determine the Potential Role of Iron Overload on Late Transplant OutcomesYvonne A Efebera, Rupinderjit S Thandi, Rima M Saliba, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 11, 2013
Proceedings from the National Cancer Institute's Second International Workshop on the Biology, Prevention, and Treatment of Relapse After Hematopoietic Stem Cell Transplantation: part III. Prevention and treatment of relapse after allogeneic transplantationMarcos de Lima, David L Porter, Minoo Battiwalla, et al.
Cancer|February 24, 2009
Low-dose azacitidine after allogeneic stem cell transplantation for acute leukemiaElias Jabbour, Sergio Giralt, Hagop Kantarjian, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 15, 2013
Feasibility of allografting in patients with advanced acute lymphoblastic leukemia after salvage therapy with inotuzumab ozogamicinPartow Kebriaei, Kaci Wilhelm, Farhad Ravandi, et al.
Leukemia Research|March 15, 2008
Altered gene expression in busulfan-resistant human myeloid leukemiaBenigno C Valdez, David Murray, Latha Ramdas, et al.
The New England Journal of Medicine|November 27, 2004
Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemiaVanderson Rocha, Myriam Labopin, Guillermo Sanz, et al.
Blood|September 24, 2008
BCR-ABL fusion transcript types and levels and their interaction with secondary genetic changes in determining the phenotype of Philadelphia chromosome-positive leukemiasDan Jones, Rajyalakshmi Luthra, Jorge Cortes, et al.
Pageof 33